135 related articles for article (PubMed ID: 10692566)
1. No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions.
Asbrink S; Zickert A; Bratt J; Gyllenhammar H; Palmblad J
Biochem Pharmacol; 2000 Apr; 59(8):1007-13. PubMed ID: 10692566
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of carvedilol on professional phagocytes.
Pecivová J; Macicková T; Lojek A; Gallova L; Cíz M; Nosál' R; Holománová D
Pharmacology; 2007; 79(2):86-92. PubMed ID: 17159380
[TBL] [Abstract][Full Text] [Related]
3. Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity.
Pecivová J; Macicková T; Lojek A; Gallová L; Cíz M; Nosál' R; Holománová D
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():160-3. PubMed ID: 17159805
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
Macickova T; Pecivova J; Nosal R; Lojek A; Pekarova M; Cupanikova D
Neuro Endocrinol Lett; 2008 Oct; 29(5):790-3. PubMed ID: 18987595
[TBL] [Abstract][Full Text] [Related]
5. Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils.
Macicková T; Pecivová J; Nosál' R; Holománová D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):389-92. PubMed ID: 16601795
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
Yue TL; McKenna PJ; Ruffolo RR; Feuerstein G
Eur J Pharmacol; 1992 Apr; 214(2-3):277-80. PubMed ID: 1355437
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin stimulates phosphoinositide turnover and phospholipase C but not phospholipase D and NADPH oxidase in human neutrophils.
Catz SD; Steŕin-Speziale NB
J Leukoc Biol; 1996 Apr; 59(4):591-7. PubMed ID: 8613709
[TBL] [Abstract][Full Text] [Related]
8. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
Wang JP; Chang LC; Lin YL; Hsu MF; Chang CY; Huang LJ; Kuo SC
Biochem Pharmacol; 2003 Apr; 65(7):1043-51. PubMed ID: 12663040
[TBL] [Abstract][Full Text] [Related]
11. Erythromycin does not directly affect neutrophil functions.
Hojo M; Fujita I; Hamasaki Y; Miyazaki M; Miyazaki S
Chest; 1994 Feb; 105(2):520-3. PubMed ID: 8306756
[TBL] [Abstract][Full Text] [Related]
12. The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro.
Bratt J; Gyllenhammar H
Arthritis Rheum; 1995 Jun; 38(6):768-76. PubMed ID: 7779119
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.
Wanikiat P; Woodward DF; Armstrong RA
Br J Pharmacol; 1997 Nov; 122(6):1135-45. PubMed ID: 9401778
[TBL] [Abstract][Full Text] [Related]
14. Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity.
Oettl K; Greilberger J; Zangger K; Haslinger E; Reibnegger G; Jürgens G
Biochem Pharmacol; 2001 Jul; 62(2):241-8. PubMed ID: 11389884
[TBL] [Abstract][Full Text] [Related]
15. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
Fantone JC; Marasco WA; Elgas LJ; Ward PA
Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
[TBL] [Abstract][Full Text] [Related]
16. Effect of the new anti-allergic compound ethyl 2-(4'-carboxybenzamido)-4-propionamidobenzoate sodium salt on human neutrophil superoxide production.
Kaneko M; Suzuki K; Furui H; Takagi K; Satake T
Arzneimittelforschung; 1990 Jan; 40(1):91-4. PubMed ID: 2160241
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
Nielsen OH; Bouchelouche PN; Berild D; Ahnfelt-Rønne I
Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human polymorphonuclear leukocyte functions by ibuprofen.
Nielsen VG; Webster RO
Immunopharmacology; 1987 Feb; 13(1):61-71. PubMed ID: 3032852
[TBL] [Abstract][Full Text] [Related]
20. Staurosporine and its derivatives enhance f-Met-Leu-Phe-induced superoxide production via phospholipase D activation in human polymorphonuclear leukocytes.
Mori T; Ando M; Takagi K
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):422-8. PubMed ID: 7981927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]